ArticleEClinicalMedicine2026

Safety and immunogenicity of bivalent RSVpreF vaccine formulated in a multidose vial in healthy female participants in the USA: a multicentre, randomised, open-label, noninferiority phase 3 study.

Uzma N Sarwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.